Arbutus Biopharma Corp logo

Arbutus Biopharma Corp

ABUS | NASDAQ
Chart Builder DCF Calculator
$5
-$0.01 (-0.20%)
At close: Sep 21, 2026, 4:00 PM ET
$5
$0 (0.00%)
Pre-market: Sep 22, 2026, 7:16 AM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
18.01M 36.33M 26.29M 30.78M 109.28M 52.25M
Short-Term Investments
73.46M 86.29M 99.72M 116.14M 46.04M 71.02M
Long-Term Investments
n/a n/a 6.28M 37.36M 35.69M n/a
Other Long-Term Assets
130K 34K n/a 103K 61K 44K
Receivables
1.75M 2.41M 1.78M 1.35M 899K 1.31M
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
1.24M 2.28M 4.25M 2.87M n/a n/a
Total Current Assets
94.46M 127.32M 132.03M 151.14M 160.66M 127.7M
Property-Plant & Equipment
32K 4.36M 6.09M 6.81M 8.07M 9.33M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
162K 4.39M 12.37M 44.28M 43.82M 9.38M
Total Assets
94.62M 131.71M 144.4M 195.42M 204.49M 137.08M
Account Payables
1.17M 2.32M 3.22M 3.52M 3.17M 2.99M
Deferred Revenue
n/a 7.57M 11.79M 16.46M n/a n/a
Short-Term Debt
547K 483K n/a 372K 383K n/a
Other Current Liabilities
2.13M 1.86M 3.7M 8.78M 3.39M n/a
Total Current Liabilities
6.01M 15.62M 22.49M 32.86M 11.22M 9.54M
Long-Term Debt
3.44M 4.83M 6.95M 10.37M 16.3M 19.55M
Other Long-Term Liabilities
8.4M 10.23M 7.6M 7.53M 5.3M 3.43M
Total Long-Term Liabilities
12.04M 18.72M 15.9M 25.71M 23.83M 25.57M
Total Liabilities
18.04M 34.34M 38.38M 58.57M 35.05M 35.11M
Total Debt
4.19M 6.12M 8.72M 12.55M 18.91M 22.54M
Book Value
76.58M 97.37M 106.02M 136.85M 169.44M 101.97M
Book Value Per Share
0.40 0.52 0.64 0.91 1.59 1.34
Common Stock
1.42B 1.41B 1.35B 1.32B 1.29B 985.94M
Retained Earnings
-1.38B -1.35B -1.28B -1.2B -1.13B -1.05B
Comprehensive Income
-48.1M -48.14M -48.42M -50.49M -48.33M -48.17M
Shareholders Equity
76.58M 97.37M 106.02M 136.85M 169.44M 101.97M
Total Investments
73.46M 86.29M 106M 153.5M 81.72M 71.02M

© 2026 bestshares.com. All rights reserved.